Cyrcadia Health
Analysis completed on 3/18/2026
Strong potential utility and technical innovation with the wearable breast cancer screening device (iTBra), but the submission is severely undermined by factually hyperbolic claims ('everyone', 'most people have used my product'), lack of verifiable traction despite a 2008 launch, and vague marketcap metrics. Actual market penetration appears minimal, placing it in the lowest calibration tier.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline